Woodcock A - Search Results

1

The Salford Lung Study protocol: a pragmatic, randomised phase III real-world effectiveness trial in asthma.

Woodcock A, Bakerly ND, New JP, Gibson JM, Wu W, Vestbo J, Leather D. Woodcock A, et al. BMC Pulm Med. 2015 Dec 10;15:160. doi: 10.1186/s12890-015-0150-8. BMC Pulm Med. 2015. PMID: 26651333 Free PMC article. Clinical Trial.

2

Measuring bronchodilation in COPD clinical trials.

Borrill ZL, Houghton CM, Woodcock AA, Vestbo J, Singh D. Borrill ZL, et al. Among authors: woodcock aa. Br J Clin Pharmacol. 2005 Apr;59(4):379-84. doi: 10.1111/j.1365-2125.2004.02261.x. Br J Clin Pharmacol. 2005. PMID: 15801931 Free PMC article.

3

A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthma.

Singh D, Kane B, Molfino NA, Faggioni R, Roskos L, Woodcock A. Singh D, et al. Among authors: woodcock a. BMC Pulm Med. 2010 Jan 8;10:3. doi: 10.1186/1471-2466-10-3. BMC Pulm Med. 2010. PMID: 20064211 Free PMC article. Clinical Trial.

4

Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial.

Woodcock A, Bateman ED, Busse WW, Lötvall J, Snowise NG, Forth R, Jacques L, Haumann B, Bleecker ER. Woodcock A, et al. Respir Res. 2011 Oct 6;12(1):132. doi: 10.1186/1465-9921-12-132. Respir Res. 2011. PMID: 21977941 Free PMC article. Clinical Trial.

5

Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma.

Woodcock A, Bleecker ER, Busse WW, Lötvall J, Snowise NG, Frith L, Jacques L, Haumann B, Bateman ED. Woodcock A, et al. Respir Res. 2011 Dec 21;12(1):160. doi: 10.1186/1465-9921-12-160. Respir Res. 2011. PMID: 22188590 Free PMC article. Clinical Trial.

6

Predictors of objective cough frequency in chronic obstructive pulmonary disease.

Sumner H, Woodcock A, Kolsum U, Dockry R, Lazaar AL, Singh D, Vestbo J, Smith JA. Sumner H, et al. Among authors: woodcock a. Am J Respir Crit Care Med. 2013 May 1;187(9):943-9. doi: 10.1164/rccm.201211-2000OC. Am J Respir Crit Care Med. 2013. PMID: 23471467

7

Efficacy and safety of fluticasone furoate/vilanterol compared with fluticasone propionate/salmeterol combination in adult and adolescent patients with persistent asthma: a randomized trial.

Woodcock A, Bleecker ER, Lötvall J, O'Byrne PM, Bateman ED, Medley H, Ellsworth A, Jacques L, Busse WW. Woodcock A, et al. Chest. 2013 Oct;144(4):1222-1229. doi: 10.1378/chest.13-0178. Chest. 2013. PMID: 23846316 Free PMC article. Clinical Trial.

8

Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: a 24-week placebo and active-controlled randomised trial.

Lötvall J, Bleecker ER, Busse WW, O'Byrne PM, Woodcock A, Kerwin EM, Stone S, Forth R, Jacques L, Bateman ED. Lötvall J, et al. Among authors: woodcock a. Respir Med. 2014 Jan;108(1):41-9. doi: 10.1016/j.rmed.2013.11.009. Epub 2013 Nov 19. Respir Med. 2014. PMID: 24295556 Free article. Clinical Trial.

9

Obtaining real-world evidence: the Salford Lung Study.

New JP, Bakerly ND, Leather D, Woodcock A. New JP, et al. Among authors: woodcock a. Thorax. 2014 Dec;69(12):1152-4. doi: 10.1136/thoraxjnl-2014-205259. Epub 2014 Mar 6. Thorax. 2014. PMID: 24603195 Free PMC article.

10

Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised study.

Woodcock A, Lötvall J, Busse WW, Bateman ED, Stone S, Ellsworth A, Jacques L. Woodcock A, et al. BMC Pulm Med. 2014 Jul 9;14:113. doi: 10.1186/1471-2466-14-113. BMC Pulm Med. 2014. PMID: 25007865 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

461 results

Search Page

Filters